Skip to main content
Clinical Trials/IRCT20230718058836N1
IRCT20230718058836N1
Completed
Phase 3

Evaluation of clinical and radiographic success and failure of Mineral trioxide aggregate (MTA) and Biodentine in pulp therapy of mandibular primary molar with reversible pulpitis in 3-6 years old children: a randomized clinical trial

Ilam University of Medical Sciences0 sites58 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Irreversible pulpitis of mandibular primary molar.
Sponsor
Ilam University of Medical Sciences
Enrollment
58
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ilam University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Initial inclusion criteria include patients who do not have any systemic diseases such as congenital or rheumatic heart disease, leukemia, allergic reactions to substances such as local anesthetics and latex, do not need general anesthesia and sedation, have good individual and family cooperation, Deep cavity lesions whose pulp is exposed during caries removal and are vital, no history of spontaneous or nocturnal pain; Absence of clinical signs such as swelling, fistula, sensitivity to precussion or palpation, pathological mobility; teeth in which hemostasis is achieved within 5 minutes during the clinical procedure; The presence of two\-thirds of the root length radiographically; and lack of radiographic evidence of pulp degeneration, such as internal or external root resorption, furca radiolucency, intraradicular or periapical bone destruction, pulp stones.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials